Clinical trial
Randomized, Double Blind Study to Evaluate the Safety and Efficacy of an Infant Formula Supplemented With Galacto-oligosaccharides (GOS) in Healthy, Full Term Infants
NCT00486148 is registered in ClinicalTrials.gov with Heinz Italia SpA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized, Double Blind Study to Evaluate the Safety and Efficacy of an Infant Formula Supplemented With Galacto-oligosaccharides (GOS) in Healthy, Full Term Infants
- Lead sponsor
- Heinz Italia SpA
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 28, 2006
- Completion date
- June 30, 2013
- Enrollment
- 360 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
nutritional safety